HSD17B13 and metabolic dysfunction-associated steatotic liver disease: The first breakthrough towards identifying the role of HSD17B13 in NAFLD pathogenesis in humans occurred when an exome-wide association study revealed that a splice variant, rs72613567 or isoform D (isoD), conferred a protective effect against NAFLD disease severity.